These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26364836)

  • 1. Monitoring for Extra-Intestinal Cancers in IBD.
    Sifuentes H; Kane S
    Curr Gastroenterol Rep; 2015 Nov; 17(11):42. PubMed ID: 26364836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
    Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
    J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do inflammatory bowel disease therapies cause cancer?
    Mason M; Siegel CA
    Inflamm Bowel Dis; 2013 May; 19(6):1306-21. PubMed ID: 23470503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's Disease.
    Garg SK; Velayos FS; Kisiel JB
    Gastroenterol Clin North Am; 2017 Sep; 46(3):515-529. PubMed ID: 28838412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma--challenges in management.
    Lee J; Clarke K
    Int J Colorectal Dis; 2015 Dec; 30(12):1595-602. PubMed ID: 26349591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?
    Garg SK; Loftus EV
    Curr Opin Gastroenterol; 2016 Jul; 32(4):274-81. PubMed ID: 27152873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
    Subramaniam K; D'Rozario J; Pavli P
    J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease].
    Kim JH; Kim JW
    Korean J Gastroenterol; 2017 Oct; 70(4):162-168. PubMed ID: 29060953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
    Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and immunomodulators in inflammatory bowel diseases.
    Biancone L; Onali S; Petruzziello C; Calabrese E; Pallone F
    Inflamm Bowel Dis; 2015 Mar; 21(3):674-98. PubMed ID: 25545375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inflammatory bowel disease and lymphoproliferative disorders].
    Ye BD
    Korean J Gastroenterol; 2011 Oct; 58(4):171-7. PubMed ID: 22042416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System.
    McKenna MR; Stobaugh DJ; Deepak P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):267-71. PubMed ID: 25267954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
    Chupin A; Perduca V; Meyer A; Bellanger C; Carbonnel F; Dong C
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1289-1297. PubMed ID: 32840893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis.
    Kobayashi T; Uda A; Udagawa E; Hibi T
    J Crohns Colitis; 2020 Jun; 14(5):617-623. PubMed ID: 31867632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease.
    Moran GW; Lim AW; Bailey JL; Dubeau MF; Leung Y; Devlin SM; Novak K; Kaplan GG; Iacucci M; Seow C; Martin L; Panaccione R; Ghosh S
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1002-24. PubMed ID: 24099467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
    Sokol H; Beaugerie L
    Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study.
    Setshedi M; Epstein D; Winter TA; Myer L; Watermeyer G; Hift R
    J Gastroenterol Hepatol; 2012 Feb; 27(2):385-9. PubMed ID: 21793904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who and how to screen for cancer in at-risk inflammatory bowel disease patients.
    Parian A; Lazarev M
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):731-46. PubMed ID: 25592672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.